Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMH.L Regulatory News (CMH)

  • There is currently no data for CMH

Trading Update

19 Jun 2020 12:15

RNS Number : 5329Q
Chamberlin PLC
19 June 2020
 

19 June 2020

Chamberlin plc

("Chamberlin" or the "Company")

 

Trading Update

 

Chamberlin plc (AIM: CMH.L), the specialist castings and engineering group, is pleased to provide a trading update following the announcement on 27 March 2020. 

 

The Company announces that the Walsall foundry reopened for production on 4 May 2020 following a three week closure. The machine shop, which also closed in April, has also reopened for production. While production levels at the Walsall factory are broadly in line with activity seen immediately prior to the impact from Covid-19, output levels at the Machine Shop are running at approximately 30% of that achieved before the COVID-19 measures.

 

Russell Ductile, the Company's Scunthorpe foundry operation, has remained open throughout and continues to operate at full production levels in response to customer demand. 

 

Petrel, Chamberlin's specialist lighting business has also remained open. However, due to suspension of a number of government and defence contracts, Petrel is operating at around 60% of normal sales volumes.

 

The health and safety of Chamberlin's employees has been, and remains, paramount. All operations are performed in line with relevant government guidelines and industry best practice specific to COVID-19 precautions. To date there have been no reported instances of any Chamberlin employee contracting COVID-19.

 

Chamberlin has taken advantage of the UK Government's measures to support business, including the furloughing of staff during the closure of the Walsall sites. The majority of employees are working normally with approximately 18% of the Company's workforce still furloughed.

 

Despite current levels of activity in the Walsall foundry being relatively high, the outlook for a number of the key markets, particularly across the automotive sector, remain uncertain. As a result, Chamberlin has taken steps to reduce costs in line with the expected reduction in demand.

 

Recognising the ongoing uncertainty across global markets, the Board continues to believe that it is too early to make any reasonable estimate of the financial impact on the Group during the current year and beyond.

 

The Company anticipates that the preliminary results for the year to 31 March 2020 will be announced in August 2020.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 

 

 

Enquiries

 

Chamberlin plc

Kevin Nolan, Chief Executive

Neil Davies, Finance Director

 

T: 01922 707100

 

 

 

 

Cenkos Securities plc (Nominated Adviser and Broker)

Russell Cook

Katy Birkin

 

T: 020 7397 8900

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGPUWUQUPUGGB
Date   Source Headline
21st Jun 20247:00 amRNSCancellation - Chamberlin PLC
20th Jun 20246:00 pmRNSChamberlin
20th May 20245:02 pmRNSAppointment of Administrators & Nomad Resignation
10th May 202412:37 pmRNSUpdate
7th May 202412:36 pmRNSSuspension of Trading
7th May 202411:45 amRNSSuspension - Chamberlin plc
22nd Apr 20247:00 amRNSHolding(s) in Company
16th Apr 202410:43 amRNSHolding(s) in Company
10th Apr 20247:00 amRNSTrading Update
5th Apr 20247:00 amRNSBoard Changes
3rd Apr 20244:12 pmRNSHolding(s) in Company
27th Feb 20241:24 pmRNSHolding(s) in Company
22nd Feb 20247:00 amRNSCompletion of Sale of Petrel Limited
21st Feb 202412:01 pmRNSSale of Petrel Limited
21st Feb 202412:00 pmRNSInterim Results
18th Jan 20243:34 pmRNSHolding(s) in Company
16th Jan 20241:20 pmRNSHolding(s) in Company
11th Jan 20246:26 pmRNSHolding(s) in Company
10th Jan 20245:12 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSPlacing and Subscription
3rd Jan 20242:41 pmRNSResult of AGM and Trading Update
15th Dec 20237:00 amRNSCorporate Update
30th Nov 20231:40 pmRNSFinal Results
28th Nov 20235:00 pmRNSHolding(s) in Company
24th Oct 20234:22 pmRNSChange of Nominated Adviser and Joint Broker
18th Oct 20232:14 pmRNSHolding(s) in Company
27th Jul 20232:00 pmRNSGrant of Share Options
24th Jul 202310:17 amRNSDirector/PDMR Shareholding
22nd Jun 20232:03 pmRNSMajor Contract Win
8th Jun 20237:00 amRNSHolding(s) in Company
26th May 20237:00 amRNSPlacing and Subscription
2nd May 20233:42 pmRNSSale and Leaseback of Walsall Property
28th Feb 20237:00 amRNSHalf-year Report
2nd Feb 20234:14 pmRNSHolding(s) in Company
1st Feb 20235:24 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSHolding(s) in Company
26th Jan 202311:53 amRNSPlacing and Subscription
19th Dec 202211:00 amRNSHolding(s) in Company
16th Dec 20221:49 pmRNSCorporate Update
30th Nov 202211:37 amRNSResult of AGM
30th Nov 20227:00 amRNSAGM Statement and Trading Update
21st Nov 20222:44 pmEQSChamberlin PLC 'left no stone unturned' during return to profit
7th Nov 20225:31 pmRNSPosting of Annual Report and Notice of AGM
4th Nov 202212:23 pmRNSFinal Results
31st Oct 202211:32 amRNSAnnouncement re: Full year results
29th Sep 20227:00 amRNSAnnouncement re: Full year results
29th Jul 20227:00 amRNSIssue of Equity and Director/PDMR Shareholding
25th Jul 20225:30 pmRNSDirector/PDMR Shareholding
18th Jul 20227:00 amRNSHolding(s) in Company
8th Jul 20225:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.